Atlas Trials

Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection

Clinical trial NCT04756271 · COMPLETED

Trial details

NCT number
NCT04756271
Sponsor
Zagazig University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Vaccine Adverse ReactionSeroconversion
Start date
2021-02-11
Primary completion
2021-12-20
Enrollment
246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.